Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercebiotech.com

FierceBiotech

Get the latest updates from FierceBiotech directly as they happen.

Follow now 337 followers

Latest posts

Last updated about 8 hours ago

Icon opens early-phase research unit in San Antonio, plus satellite clinics to grow trial capabilities

about 8 hours ago

Global contract research organization Icon has announced the opening of a new...

With $1B Novo deal and diabetes ambitions undimmed, Lexicon is in ‘good shape to go crazy’

about 11 hours ago

Three weeks into taking on the role of Lexicon Pharmaceuticals CEO back...

Humacyte cuts spending, staff as it seeks to boost sluggish sales for its off-the-shelf artery implant

about 11 hours ago

Humacyte was riding high in December 2024 when it secured an FDA...

Fosun pays $60M for option on AriBio’s phase 3 Alzheimer’s asset

about 12 hours ago

Fosun Pharma has paid $60 million for an option on AriBio’s late-phase...

Valneva to lay off up to 15% of workforce in face of ‘adverse trend‘ in travel vaccines

about 13 hours ago

Valneva is planning to shrink its headcount by up to 15% as...

Medtronic to shutter Santa Rosa plant as it restructures cardio vascular unit

about 13 hours ago

Medtronic will shutter its Santa Rosa facility that produces coronary stents and...

Takeda 0 for 4 against nausea and vomiting after axing another asset

about 16 hours ago

Takeda has ended development of its nausea and vomiting drug candidate for...

AstraZeneca pens agentic AI licensing deal with Owkin

about 20 hours ago

AstraZeneca is the latest Big Pharma company looking to tap into agentic...

Kyverna begins rolling submission for autoimmune CAR-T as FDA requests more natural history analysis

1 day ago

Kyverna Therapeutics has officially started a rolling submission to the FDA for...

FDA Commissioner Marty Makary to resign, capping turbulent tenure: report

1 day ago

Marty Makary, M.D., is resigning as FDA commissioner Tuesday, ending a brief...

Charles River debuts AI diagnostic tool to cut down pathology timelines

1 day ago

Charles River is rolling out an artificial intelligence-backed digital pathology platform with...

Alphabet's AI biotech Isomorphic Labs bags $2.1B series B to fuel next-gen drug design model

1 day ago

If any proof was needed that big money is still available for...